Rhythm Pharmaceuticals
RYTM
RYTM
124 hedge funds and large institutions have $1.01B invested in Rhythm Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less capital invested
Capital invested by funds: $1.19B → $1.01B (-$183M)
25% less call options, than puts
Call options by funds: $1.05M | Put options by funds: $1.39M
Holders
124
Holding in Top 10
2
Calls
$1.05M
Puts
$1.39M
Top Buyers
| 1 | +$35.4M | |
| 2 | +$24.8M | |
| 3 | +$24.7M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$24.2M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$14.7M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$21.3M | |
| 3 | -$15.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.59M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.42M |